Kistler-Tiffany Companies Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mesa Laboratories
MLAB
|
+$6.54M |
| 2 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$4.83M |
| 3 |
State Street SPDR S&P Dividend ETF
SDY
|
+$1.05M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$973K |
| 5 |
Schwab US Mid-Cap ETF
SCHM
|
+$826K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$2.88M |
| 2 |
Exelon
EXC
|
+$317K |
| 3 |
Vanguard High Dividend Yield ETF
VYM
|
+$313K |
| 4 |
Verizon
VZ
|
+$279K |
| 5 |
RTX Corp
RTX
|
+$272K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.99% |
| 2 | Technology | 8.32% |
| 3 | Consumer Staples | 4.58% |
| 4 | Communication Services | 4.11% |
| 5 | Financials | 3.97% |
Similar funds
Kistler-Tiffany Companies's Q2 2019 Portfolio in Review
As of Q2 2019, Kistler-Tiffany Companies held 604 positions worth $263M, up 8.8% from $242M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Kistler-Tiffany Companies deployed $14.5M of net new capital in Q2 2019, opening 28 new positions and adding to 145 existing holdings. Its largest new stake was Dow Inc: 6,430 shares worth $317K.
By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 12% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was West Pharmaceutical, an estimated $2.88M trimmed.
- Kistler-Tiffany Companies's largest Q2 2019 buy was Dow Inc: 6,430 shares worth $317K.
- Kistler-Tiffany Companies added most to Mesa Laboratories in Q2 2019, an estimated $6.54M increase.
- Kistler-Tiffany Companies's biggest Q2 2019 reduction was West Pharmaceutical, cutting an estimated $2.88M.
- Kistler-Tiffany Companies fully exited Blackstone in Q2 2019, selling an estimated $251K.
- Kistler-Tiffany Companies's ten largest holdings make up 51% of its $263M portfolio in Q2 2019.
- Kistler-Tiffany Companies opened 28 new positions and closed 25 in Q2 2019.
- Kistler-Tiffany Companies's portfolio value rose 8.8% quarter-over-quarter to $263M.
Based on Kistler-Tiffany Companies's 13F filing for Q2 2019, filed 22 Jul 2019.